✦ LIBER ✦

Wed-P51 - Ziprasidone in the long-term treatment of negative symptoms and prevention of exacerbation of schizophrenia

✍ Scribed by M. Arato; R. O’Connor; J.E. Bradbury; H. Meltzer

Book ID: 119574240
Publisher: Elsevier Science
Year: 1998
Tongue: French
Weight: 133 KB
Volume: 13
Category: Article
ISSN: 0924-9338
DOI: 10.1016/s0924-9338(99)80610-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.067 Ziprasidone: Efficacy in the pre

P.2.067 Ziprasidone: Efficacy in the prevention of relapse and in the long-term treatment of negative symptoms of chronic schizophrenia

✍ M. Arató; R. O'Connor; H. Meltzer; J. Bradbury 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 148 KB

P.3.c.081 Efficacy of amisulpride, aripi

P.3.c.081 Efficacy of amisulpride, aripiprazole and ziprasidone in the treatment of negative symptoms in schizophrenia

✍ M. Gheorghe; G. Grigorescu; A. Baloescu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

P.3.e.013 Long-term efficacy of repetiti

P.3.e.013 Long-term efficacy of repetitive TMS in the treatment of negative symptoms of schizophrenia

✍ R. Prikryl; L. Ustohal; T. Kasparek; S. Venclikova; H. Kucerova; E. Ceskova 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

P.2.111 Long-term effects of aripirazole

P.2.111 Long-term effects of aripirazole on the negative symptoms of schizophrenia

✍ D. Kostic; G. Manos; E. Stock; D. Jody; D. Archibald; S. Tourkodimitris; R. Marc 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 139 KB

The long-term treatment of schizophrenia

The long-term treatment of schizophrenia and prevention of relapse

✍ J. Gerlach 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 177 KB

A pilot study of intramuscular ziprasido

A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia

✍ Shlomo Brook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Ziprasidone is a novel antipsychotic which, in oral formulation, has been shown to be effective and well tolerated in the treatment of acute psychosis. This pilot study examined the efficacy and tolerability of the intramuscular (IM) formulation and the transition from IM to oral ziprasidone in pati